LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Inicio・Lista de Acciones・Neurocrine Biosciences Inc

Neurocrine Biosciences Inc

Abierto

Sector Salud

122.88 0.56

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

121.82

Máximo

123.25

Métricas clave
By Trading Economics
Ingresos	22M 65M
Ventas	65M 580M
P/B Media del Sector	37.41 103.001
BPA	1.63
Margen de beneficio	11.207
Empleados	1,400
EBITDA	113M 155M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+37.42 upside

Dividendos
By Dow Jones
Próximas Ganancias	29 oct 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-2.3B 13B
Apertura anterior	122.32
Cierre anterior	122.88

Noticias sobre sentimiento de mercado

By Acuity

50%

97 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

119.92 / 122.54 Soporte y Resistencia

Neurocrine Biosciences Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

13 ago 2024, 11:30 UTC

Principales Noticias

S&P 500 Futures Climb In Premarket Trading; On Holding, Western Midstream Ptrs Lag

7 dic 2023, 18:34 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Neuro-Drug Makers Looking Valuable After AbbVie-Cerevel Deal -- Market Talk

Comparación entre iguales

Cambio de precio

Neurocrine Biosciences Inc Esperado

Precio Objetivo

By TipRanks

37.42% repunte

Estimación a 12 meses

Media 168 USD 37.42%

Máximo 219 USD

Mínimo 128 USD

De acuerdo con 22 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Neurocrine Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

22 ratings

Comprar

Mantener

Vender

De acuerdo con 22 analistas que ofrecen calificaciones bursátiles a para Neurocrine Biosciences Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

119.92 / 122.54Soporte y Resistencia

Bearish events outweigh bullish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Sentimiento

By Acuity

97 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering, developing, and delivering treatments for people with neurological, endocrine and psychiatric disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis, uterine fibroids, and clinical programs in multiple therapeutic areas. The Company's product pipeline includes INGREZZA (valbenazine), which provides a once-daily dosing treatment option for tardive dyskinesia and has two dosing options (40 milligram (mg) and 80 mg capsules). ONGENTYS (opicapone) is an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease. ORILISSA (elagolix) is used for the management of moderate to severe endometriosis pain in women. ORIAHNN (elagolix, estradiol, and norethindrone acetate; elagolix) is a non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in women.